MediciNova Receives Notice of Patent Allowance for Method of Treating Acute … – NASDAQ
|
MediciNova Receives Notice of Patent Allowance for Method of Treating Acute …
NASDAQ 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), announced that it has … |
